Lusochimica Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is IPRATROPIUM BROMIDE, with a corresponding US DMF Number 8979.
Remarkably, this DMF maintains an Active status since its submission on February 15, 1991, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 05, 2015, and payment made on January 27, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II